Javascript must be enabled to continue!
Serum Lipid Profile and HbA<sub>1c</sub> Status in Different Group of Diabetic Patients
View through CrossRef
Background: Diabetes mellitus is a common endocrine and metabolic problem all over the world. Type 2 diabetic patients have an increased prevalence of dyslipidemia which commonly manifests as raised low- density lipoprotein (LDL), decreased high density lipoprotein (HDL) or elevated triglycerides (TG) levels and causes public health problems worldwide as well as in our country. Glycated hemoglobin is used as a biomarker of long-term glycemic control which is beneficial to prevent developing complications and achieve the goal of treatment. Aim of the study: To observe serum lipid profile and HbA1C level status in different groups of diabetic patients. Methods: This cross-sectional study was conducted in the Outpatient Department of Shaheed Ziaur Rahman Medical College Hospitcross-sectional18 to June 2019. A total num Outpatient objects (34 males and 56 females) were selected with the age above 18 years on the basis of exclusion and inclusion criteria. Under aseptic precaution 5ml venous blood was collected from the subjects and analyzed to assess HbA1C and lipid profile. Data were collected in a predesigned structured questionnaire form by us. For statistical analysis, one way ANOVA test, Unpaired Student’s test and Pearson’s correlation coefficient (r) test were performed by using SPSS windows, version 22.0. P value <0.05 was accepted as level of significance. Result: In our study, 57.9% male diabetic patients on therapy and 46.7% male newly diagnosed diabetic patients had dyslipidemia. 53.8% female diabetic patients on therapy and 76.7% female newly diagnosed diabetic patients had dyslipidemia. There were no significant differences observed between lipid profile of diabetic patients on therapy and newly diagnosed diabetic patients, but statistically significant difference observed between HbA1C levels of diabetic patients on therapy and newly diagnosed diabetic patients. In our study, 15.8% male diabetic patients on therapy and 100% male newly diagnosed diabetic patients had HbA1C ≥ 6.5%. 15.4% female diabetic patients on therapy and 100% female newly diagnosed diabetic patients had HbA1C levels ≥ 6.5%. Positive correlation was found between HbA1C levels and TG, TC, LDL but HDL level showed negative correlation with HbA1C. Conclusion: This study concludes that, there were no significant differences between lipid profile of diabetic patients on therapy and newly diagnosed diabetic patients, but statistically significant difference was found between HbA1C levels of diabetic patients on therapy and newly diagnosed diabetic patients. The pattern of diabetic dyslipidemia was high triglycerides and low high-density lipoprotein. Positive correlation was found between HbA1C levels and TG, TC, LDL but HDL level showed negative correlation with HbA1C.
Ordient Publishers
Title: Serum Lipid Profile and HbA<sub>1c</sub> Status in Different Group of Diabetic Patients
Description:
Background: Diabetes mellitus is a common endocrine and metabolic problem all over the world.
Type 2 diabetic patients have an increased prevalence of dyslipidemia which commonly manifests as raised low- density lipoprotein (LDL), decreased high density lipoprotein (HDL) or elevated triglycerides (TG) levels and causes public health problems worldwide as well as in our country.
Glycated hemoglobin is used as a biomarker of long-term glycemic control which is beneficial to prevent developing complications and achieve the goal of treatment.
Aim of the study: To observe serum lipid profile and HbA1C level status in different groups of diabetic patients.
Methods: This cross-sectional study was conducted in the Outpatient Department of Shaheed Ziaur Rahman Medical College Hospitcross-sectional18 to June 2019.
A total num Outpatient objects (34 males and 56 females) were selected with the age above 18 years on the basis of exclusion and inclusion criteria.
Under aseptic precaution 5ml venous blood was collected from the subjects and analyzed to assess HbA1C and lipid profile.
Data were collected in a predesigned structured questionnaire form by us.
For statistical analysis, one way ANOVA test, Unpaired Student’s test and Pearson’s correlation coefficient (r) test were performed by using SPSS windows, version 22.
P value <0.
05 was accepted as level of significance.
Result: In our study, 57.
9% male diabetic patients on therapy and 46.
7% male newly diagnosed diabetic patients had dyslipidemia.
53.
8% female diabetic patients on therapy and 76.
7% female newly diagnosed diabetic patients had dyslipidemia.
There were no significant differences observed between lipid profile of diabetic patients on therapy and newly diagnosed diabetic patients, but statistically significant difference observed between HbA1C levels of diabetic patients on therapy and newly diagnosed diabetic patients.
In our study, 15.
8% male diabetic patients on therapy and 100% male newly diagnosed diabetic patients had HbA1C ≥ 6.
5%.
15.
4% female diabetic patients on therapy and 100% female newly diagnosed diabetic patients had HbA1C levels ≥ 6.
5%.
Positive correlation was found between HbA1C levels and TG, TC, LDL but HDL level showed negative correlation with HbA1C.
Conclusion: This study concludes that, there were no significant differences between lipid profile of diabetic patients on therapy and newly diagnosed diabetic patients, but statistically significant difference was found between HbA1C levels of diabetic patients on therapy and newly diagnosed diabetic patients.
The pattern of diabetic dyslipidemia was high triglycerides and low high-density lipoprotein.
Positive correlation was found between HbA1C levels and TG, TC, LDL but HDL level showed negative correlation with HbA1C.
Related Results
Estimation of post-transfusion HbA level is relevant after RBC exchange in sickle cell adult patients
Estimation of post-transfusion HbA level is relevant after RBC exchange in sickle cell adult patients
Abstract
Background Transfusion (TF), or exchange transfusion (ExTF), is a major therapy for sickle cell disease (SCD) p...
Emerging Evidence of IgG4-Related Disease in Pericarditis: A Systematic Review
Emerging Evidence of IgG4-Related Disease in Pericarditis: A Systematic Review
Abstract
Introduction
Immunoglobulin G4-related disease (IgG4-RD) is a recently identified immune-mediated condition that is debilitating and often overlooked. While IgG4-RD has be...
Glycometabolic Control and Fibrinolysis in Diabetic Patients
Glycometabolic Control and Fibrinolysis in Diabetic Patients
We investigated 148 diabetic patients with regard to their relationship between fibrinolysis (D-dimer and plasminogen activator inhibitor; PAI) and glycometabolic control (HbA<s...
Small Cell Lung Cancer and Tarlatamab: A Meta-Analysis of Clinical Trials
Small Cell Lung Cancer and Tarlatamab: A Meta-Analysis of Clinical Trials
Abstract
Introduction
Tarlatamab is a Delta-like ligand 3 (DLL3) -directed bispecific T-cell engager recently approved for use in patients with advanced small cell lung cancer (SCL...
Abstract P230: Measures of Glycaemia (Fasting and 2 hr Glucose, Glycosylated Haemoglobin) in Relation to Incident Vascular Disease in Non-diabetic Adults
Abstract P230: Measures of Glycaemia (Fasting and 2 hr Glucose, Glycosylated Haemoglobin) in Relation to Incident Vascular Disease in Non-diabetic Adults
Introduction:
Glycosylated haemoglobin (HbA
1c
) has recently been accepted for diagnosing diabetes in New Zealand. A 2 hour 75g oral glucose te...
Combined measurement uncertainty of HbA
1c
and glucose using ISO 20914:2019 and outcome-based simulation
Combined measurement uncertainty of HbA
1c
and glucose using ISO 20914:2019 and outcome-based simulation
Abstract
Objectives
This study aimed to calculate the measurement uncertainty (MU) of HbA
...
Platform Session B: Clinical Neurophysiology/Clinical Epilepsy
3:00 p.m.–6:00 p.m.
Platform Session B: Clinical Neurophysiology/Clinical Epilepsy
3:00 p.m.–6:00 p.m.
1
Jose F.
Tellez‐Zenteno,
1
Scott B.
Patten, and
1
Samuel
Wiebe
...
ASSOCIATION OF THE SERUM LEVELS OF C-REACTIVE PROTEIN WITH ITS GENE POLYMORPHISMS AND ACUTE CORONARY SYNDROME
ASSOCIATION OF THE SERUM LEVELS OF C-REACTIVE PROTEIN WITH ITS GENE POLYMORPHISMS AND ACUTE CORONARY SYNDROME
Objectives
To investigate the association of the serum levels of CRP with its gene polymorphisms and the risk of ACS in Chinese Han population in Sunan region.
...

